Share This

 

Dear Friend,

The LSI has been getting questions about the COVID-19 virus and lupus.  We asked Dr. Robert Katz to put together information the lupus community may find helpful.

Together, we make a difference,

Mary

Lupus & Covid-19
     By Dr. Robert Katz

About COVID-19 & lupus

COVID-19 is a coronavirus – one of a large family of viruses that are common in people and many different species of animals.  80% of people who contract the virus will have mild symptoms.  COVID-19 began in Wuhan, Hubei Province, China and has since spread to many countries and the United States.

Are people living with lupus at greater risk of infection from COVID-19?

People living with lupus are at greater risk of infection due to their autoimmune disease and some of the medications they may be taking.

It is important to continue taking your prescribed medication and taking care of yourself as you have been for lupus.

MORE

Associate Board

Steppin' Out for Lupus Dinner Dance

The LSI Associate Board is hosting a fundraiser to benefit the LSI's mission!  It promises to be an eventful night with live music, educational speakers and a silent auction!

Friday, April 24, 2020 | 6:30 PM CDT  to 11:30 PM CDT

Educational Opportunities

Click image to register for this webinar

Illinois Lupus Walks

Click image for more

Click image for more

Click image for more

Lupus Charity Runners

Click image for more

Click image for more

Research Opportunities

Lupus Intervention Fatigue Trial

If you have lupus and suffer from low energy or you feel tired often, you may qualify for the Lupus Intervention Fatigue Trial (LIFT) – a study being done to test two treatment programs to help people with lupus better manage their fatigue.

For more information, download the flyer here

STUDY OF OMEGA-3 REPLACEMENT WITH KRILL OIL IN TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS

The study is a 24 week randomized, double-blind controlled multicenter study followed by an open label extension treatment for another 24 weeks. The purpose of this study is to determine whether the correction of the omega-3 deficiency may reduce disease activity in SLE patients.

For more information, download the flyer here.

 
 
 

Our Mission

LSI promotes lupus awareness and complements the work of health care professionals by providing personalized resources for the lupus community while supporting research.

312-542-0002 | 800-258-7872 | info@lupusil.org
Follow us!

Unsubscribe